Pen Needles Market Overview
As per Econ Market Research analysis, the Global Pen Needles Market was recorded at US$ 1.86 Billion in 2026 and is projected to expand to US$ 3.82 Billion by 2035, registering a CAGR of 8.3% over the forecast period. The base year used is 2025.
Pen needles are crucial parts of insulin pens and other Drug delivery systems that make it easier for people to administer medication comfortably and painlessly, especially for those who have diabetes. With its introduction, traditional syringes and vials were replaced with a more user-friendly option, completely changing the way patients maintain their health.
Pencil needles were initially quite basic, but they have undergone significant design, length, gauge, and safety feature developments over time. With injections, patients are now much more comfortable and have less anxiety and pain because shorter, finer gauge needles have been introduced. Furthermore, the general safety profile of pen needles has been improved by the incorporation of safety devices such needle shields and retractable features. Pen needle sales have also been impacted by the growing use of injectable medications for a range of medical ailments and the increased incidence of diabetes worldwide.
Because of this, the market for pen needles has grown to be a very active and competitive sector, with many manufacturers continuously coming up with new products to fulfill the changing needs of consumers and healthcare professionals. The importance of environmental sustainability has grown recently, which has prompted the creation of disposable, eco-friendly pen needles. Pen needles, which provide a more comfortable and convenient way to administer medication, have had a significant impact on healthcare since their debut and development. As the industry grows to meet the evolving needs of the healthcare sector, pen needle sales will only increase.
Market Dynamics
One of the biggest factors driving the pen needles market is the rising prevalence of diabetes worldwide. Since people with diabetes need to regularly inject insulin, pen needle demand is only increasing. The market is growing because of continuous developments in pen needle design, such as thinner and shorter needles, improved safety features, and interoperability with different pen injector devices.
The comfort and adherence of patients are the goals of these advances. The market is growing as a result of patients', growing preference for pen needles over traditional syringes because of their portability, convenience of use, and less pain. Patient preferences are accommodated via improved needle technology and user-friendly designs. Market dynamics are impacted by changing medical device standards and regulations. Strict quality and safety regulations that manufacturers must adhere to have an impact on product development and market access.
Innovation is encouraged in a highly competitive market where many firms are constantly offering new products and technology in an attempt to obtain a competitive advantage. Price alterations and market consolidation can result from this competition. An emerging trend that is changing market dynamics is the integration of digital health technology with smart pen needle devices to help with medication adherence and data monitoring. Disposable and eco-friendly pen needles are becoming more popular, which is indicative of rising environmental consciousness and influencing consumer behavior. The market for pen needles is being impacted by broader healthcare trends including Telemedicine and home healthcare. The need for dependable and user-friendly pen needle solutions is being driven by the growing number of patients who are taking care of their health from home.
Market Drivers
Increasing Diabetes Prevalence
This driver is typified by the rising number of people receiving diabetes diagnoses, particularly type 2 diabetes, which is frequently linked to lifestyle choices like eating poorly and not exercising. Together with an increase in obesity rates, the sedentary lifestyle of today is one of the main causes of the rise in diabetes prevalence. People who make poor dietary choices such as eating a lot of processed foods and sugar are more likely to gain weight and develop insulin resistance, which increases their risk of developing diabetes. An other factor contributing to the rising incidence of diabetes is the demographic change towards an older population.
The condition is more common in older people, and as life expectancy increases, there will likely be an increase in the number of older people with diabetes. The healthcare industry is compelled to focus on diabetes prevention, improved management, and the development of innovative treatments. Public health initiatives, lifestyle interventions, and early diabetes detection are vital components of efforts to mitigate the impact of this growing health crisis.
Rising Healthcare Expenditure
It includes rising expenses for medical services and treatments as well as general infrastructure upkeep for the healthcare system. There are several reasons behind this continuing pattern. Novel, but frequently costly, treatments and therapies have been developed as a result of developments in pharmaceuticals and medical technology. Although these innovations have enhanced patient care, they come at a higher cost, driving up the entire cost of providing healthcare.
The number of people living longer is a major factor in the increase in healthcare costs. People tend to need more medical attention and treatment for age-related health conditions as they live longer. Due to the fact that older people typically use healthcare services more frequently, this demographic shift has a significant negative impact on healthcare systems. Moreover, healthcare infrastructure and facilities demand significant investments in maintenance and expansion. Ensuring state-of-the-art healthcare facilities and technology infrastructure adds to the financial burden.
Restraints
High product costs might make it difficult for people to receive necessary medical procedures and treatments in the healthcare industry. Disparities in healthcare outcomes can result from patients', inability to pay for prescription drugs, medical equipment, or treatments. Furthermore, the cost of healthcare can put a pressure on government spending and healthcare systems, which could lower the general standard of care that the general public receives. Adoption of new technologies can also be hampered by high product costs.
Innovative products in sectors such as consumer electronics are frequently expensive, limiting their availability to a larger market. This exclusivity can limit the benefits of these breakthroughs to a small group of people and slow down the rate of technological adoption. Moreover, high product costs can be a barrier to market entry for businesses, particularly small startups and entrepreneurs. They can find it challenging to compete in markets where established players can offer similar products at lower prices due to economies of scale.
Needlestick Injury Concerns
Bloodborne pathogens like HIV, hepatitis B, and hepatitis C can spread by needlestick damage. A major health risk is posed to the injured person by the possibility of infection, which calls for diagnostics and medical attention. Affected healthcare workers can also experience significant emotional and psychological effects from needlestick injuries, including stress and anxiety. Moreover, the expenses of healthcare are raised by needlestick injuries. Treatment for illnesses resulting from exposure to exposure can be costly and can involve testing, counseling, and possibly antiviral medication.
Medical facilities and employers have a financial burden in part because of these expenses as well as missed work hours and payout claims. The job satisfaction and retention rates of healthcare personnel might also be impacted by the dread of needlestick injuries. Employees can feel more anxious and stressed out, which could have an impact on their general wellbeing and productivity. Over time, this can result in a labor shortage in vital healthcare industries.
Opportunities
Advancements in Pen Needle Technology
A significant opportunity is to improve patient comfort and adherence. Because of their shorter, finer, and smoother shape, advanced pen needles can greatly lessen the pain and suffering that come with injections. More adherence to prescription regimens as a result of increased comfort can eventually lead to better health results. Furthermore, there is a significant chance to lower the incidence of needlestick injuries and improve user safety by including safety measures into pen needles. For example, protected or retractable needles reduce the chance of unintentional punctures, safeguarding both patients and medical personnel.
Integration of digital health is an additional promising path. Patients can track and control their injection schedules with the use of smart pen needles and related smartphone apps, which include dose calculations, data analysis, and reminders for improved illness management. This opportunity aligns with the broader trend of digital health and patient empowerment. Environmental sustainability is a growing concern, leading to eco-friendly and disposable pen needles. This innovation not only reduces the environmental footprint but also aligns with changing consumer preferences for greener healthcare options.
Home Healthcare and Self-Administration
Self-administration and at-home medical care give patients the power to take charge of their health. Under the direction of medical specialists, people can take control of their diseases, get the treatments they need, and keep an eye on their health, which improves patient involvement and self-care. This patient-centered strategy can result in enhanced quality of life and better outcomes. Furthermore, patients and healthcare systems can save money by having the option to receive medical care at home. Compared to at-home options, hospital stays and inpatient care are frequently more costly. This cost-effectiveness is especially crucial as healthcare spending gets more and more constrained.
Additionally, developments in telemedicine and remote monitoring technology have made it possible for medical professionals to evaluate and communicate with patients from a distance, improving access to care and extending the reach of their expertise. This can be especially beneficial for patients in rural or underserved areas. Home healthcare also presents opportunities for caregivers, as it can reduce the burden on family members and professional caregivers who provide support for patients, particularly those with chronic conditions or special needs.
Segment Overview
By Product
Based on product, the global pen needles market is divided into standard &, safety pen needles. The safety pen needles-based category dominates the market with the largest revenue share in 2022. Safety pen needles represent an essential innovation in healthcare. These needles are equipped with various safety features, such as needle shields or retractable mechanisms, aimed at minimizing the risk of accidental needlestick injuries. Safety pen needles are particularly important for healthcare professionals and patients who self-administer injections, ensuring their protection and peace of mind during and after use. Standard pen needles and safety pen needles, each serving distinct purposes in the field of healthcare. Standard pen needles are the traditional, widely used devices for administering medications like insulin to patients, commonly employed in the treatment of conditions such as diabetes. They are designed to be simple and effective, focusing on efficient medication delivery with minimal discomfort.
By Needle Length
Based on the needle length, the global pen needles market is categorized into 4mm, 5mm, 6mm, 8mm, 10mm, 12mm. The 8mm category leads the global pen needles market with the largest revenue share in 2022. These needles are of standard length and are commonly used for subcutaneous injections. They work well for patients who have a moderate amount of subcutaneous fat. 4mm pen needles are the shortest pen needles available and are often preferred for individuals who have a lower amount of subcutaneous fat. They are designed to reduce the risk of intramuscular injection and can offer greater comfort during injection.
5mm pen needles are slightly longer than 4mm, these needles are still considered short and are suitable for patients with varying levels of subcutaneous fat. They are popular for their ease of use and reduced risk of pain. 6mm pen needles strike a balance between short and standard lengths, suitable for a wide range of patients. They are versatile and user-friendly, often chosen for their compatibility with most injection techniques.
10mm pen needles are slightly longer than standard needles, these are chosen when injections need to penetrate deeper subcutaneous layers. They are particularly useful for patients with thicker skin or fatty tissue. 12mm pen needles are the longest among the available options and are typically used when a deeper injection is required, such as for specific medications or in patients with considerable subcutaneous fat.
By Therapy
Based on therapy, the global pen needles market is segmented into insulin, glucagon-like-peptide-1. The insulin segment dominates the pen needles market. This segment caters to patients who require insulin therapy, which is essential for individuals with diabetes, especially those with type 1 diabetes and some cases of type 2 diabetes. Insulin pen needles are designed to deliver insulin subcutaneously, allowing for controlled and precise dosage administration. These pen needles are available in various lengths and gauges to accommodate the diverse needs of insulin-dependent individuals.
The market for insulin pen needles is substantial, given the global prevalence of diabetes, and it continues to grow as diabetes diagnoses increase. GLP-1 is a type of medication used to treat type 2 diabetes by regulating blood sugar levels and potentially promoting weight loss. The pen needles in this segment are specifically designed for the administration of GLP-1 agonists, ensuring accurate and efficient delivery. The market for GLP-1 pen needles has emerged in response to the increasing adoption of GLP-1-based therapies as a part of the treatment regimen for type 2 diabetes.
By Distribution Channel
Based on distribution channel, the global pen needles market is divided into hospital pharmacies, drug stores and retail pharmacies, online providers. The drug stores and retail pharmacies based category dominates the market with the largest revenue share in 2022. Local drug stores and retail pharmacies are accessible and common sources of pen needles for patients with prescription needs. These establishments offer convenience to individuals who prefer to pick up their supplies in person, making it easier for them to manage their medication regimens.
Retail pharmacies can provide a variety of pen needle options, as well as guidance from pharmacists on selecting the most suitable product. Hospital pharmacies play a vital role in the distribution of pen needles, especially for inpatient care and emergency situations. They provide a convenient source of these devices for healthcare professionals working within hospital settings. Hospital pharmacies ensure that a steady supply of pen needles is available to meet the needs of patients undergoing treatment, including those with diabetes or other conditions requiring injectable medications.
The rise of e-commerce has given birth to online providers who offer pen needles through digital platforms. This option grants patients the flexibility to order their supplies online and have them delivered directly to their homes. Online providers often maintain a diverse range of pen needle options, allowing patients to choose the specific product that best fits their needs. The convenience of online ordering is particularly beneficial for those with mobility challenges or those seeking a wide selection of needle types and sizes.
Overview by Region
The global pen needles market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World. North America emerged as the leading region, capturing the largest market share in 2022. In the global market for pen needles, North America has solidified its position as the top region. This significance is a result of the area',s highly developed healthcare system, high diabetes prevalence, and proactive adoption of cutting-edge medical technologies.
A sizable portion of the populations in the US and Canada have diabetes, both type 1 and type 2. Pen needles are in high demand because these patients require daily insulin injection. Due to the market',s increased innovation and competition as a result of this predominance, a large variety of pen needle alternatives are now available. Furthermore, when it comes to medical technology, research, and development, North America leads the world. As a result, pen needle technology has continued to advance, improving patient comfort and safety.
The region has embraced safety elements like retractable mechanisms and needle shields, which lower the likelihood of needlestick injuries. Pen needles are easily accessible for patients and healthcare workers thanks to the region',s well-established healthcare system, which consists of clinics, hospitals, and retail pharmacies. Online service providers have also grown in popularity, which improves accessibility and convenience even further. It is anticipated that North America will maintain its market-leading position for pen needles as long as it is dedicated to enhancing patient care and diabetes treatment.
Competitive Landscape
In the global pen needles market, a few major players exert significant market dominance and have established a strong regional presence. These leading companies remain committed to continuous research and development endeavors and actively engage in strategic growth initiatives, including product development, launches, joint ventures, and partnerships. By pursuing these strategies, these companies aim to strengthen their market position, expand their customer base, and capture a substantial share of the market.
Key Players
Owen Mumford Ltd.
Novo Nordisk A/S
B. Braun SE
Embecta Corp.
MTD Medical Technology and Devices S.p.A.
UltiMed, Inc.
Ypsomed AG
Allison Medical, Inc.
Trividia Health, Inc.
Terumo Corporation
BD (Becton, Dickinson and Company)
HTL-STREFA S.A.
Artsana S.p.A.
Hindustan Syringes & Medical Devices Ltd.
Recent Developments
In June 2023, the primary shareholder of BIOCORP, BIO JAG, and Novo Nordisk have initiated exclusive discussions for the purchase of BIO JAG',s full position in BIOCORP, which represents 45.3% of the company',s share capital and 62.2% of its theoretical voting rights, at a price per share of 35.00 euros.
Pen Needles Market Segmentation
| Segment Category | Segment Values |
|---|---|
| Type |
|
| Length |
|
| Therapy |
|
Key Players
- Embecta (BD)
- Novo Nordisk
- B. Braun
- Ypsomed AG
- Owen Mumford
- Terumo
- NIPRO Corporation
- HTL-STREFA
Table of Contents
1. GLOBAL PEN NEEDLES MARKET–REPORT OVERVIEW
- 1.1. SCOPE OF THE REPORT
- 1.2. MARKET SEGMENT ANALYSIS
- 1.3. REGULATORY SCENARIO BY REGION/COUNTRY
- 1.4. MARKET INVESTMENT SCENARIO STRATEGIC
- 1.5. MARKET ANALYSIS BY BY TYPE (USD MILLION)
- 1.5.1 GLOBAL PEN NEEDLES MARKET SHARE BY BY TYPE (2026-2035)
- 1.5.2 STANDARD PEN NEEDLES
- 1.5.3 SAFETY PEN NEEDLES
- 1.6. GLOBAL PEN NEEDLES MARKET SHARE BY BY TYPE IN 2026 & 2035
- 1.7. MARKET ANALYSIS BY BY LENGTH (USD MILLION)
- 1.7.1 GLOBAL PEN NEEDLES MARKET SHARE BY BY LENGTH (2026-2035)
- 1.7.2 4MM
- 1.7.3 5MM
- 1.7.4 6MM
- 1.7.5 8MM
- 1.7.6 10MM
- 1.7.7 12MM
- 1.8. GLOBAL PEN NEEDLES MARKET SHARE BY BY LENGTH IN 2026 & 2035
- 1.9. MARKET ANALYSIS BY BY THERAPY (USD MILLION)
- 1.9.1 GLOBAL PEN NEEDLES MARKET SHARE BY BY THERAPY (2026-2035)
- 1.9.2 INSULIN
- 1.9.3 GLP-1
- 1.9.4 GROWTH HORMONE
- 1.10. GLOBAL PEN NEEDLES MARKET SHARE BY BY THERAPY IN 2026 & 2035
2. DRIVER RESTRAINT CHALLENGE AND OPPORTUNITIES OF PEN NEEDLES MARKET
- 2.1. DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
- 2.1.1 MARKET DRIVER ANALYSIS
- 2.1.2 MARKET RESTRAINT ANALYSIS
- 2.1.3 MARKET OPPORTUNITY
- 2.2. MARKET CHALLENGES
3. GLOBAL GROWTH TRENDS
- 3.1. INDUSTRY TRENDS
- 3.1.1 SWOT ANALYSIS
- 3.1.1.1 Strengths
- 3.1.1.2 Weaknesses
- 3.1.1.3 Opportunities
- 3.1.1.4 Threats
- 3.1.2 PESTEL ANALYSIS
- 3.1.2.1 Political Landscape
- 3.1.2.2 Economic Landscape
- 3.1.2.3 Social Landscape
- 3.1.2.4 Technological Landscape
- 3.1.2.5 Environmental Landscape
- 3.1.2.6 Legal Landscape
- 3.1.3 PORTER'S FIVE FORCES ANALYSIS
- 3.1.3.1 Bargaining Power of Suppliers
- 3.1.3.2 Bargaining Power of Buyers
- 3.1.3.3 Threat of Substitute
- 3.1.3.4 Threat of New Entrant
- 3.1.3.5 Competitive Rivalry
- 3.1.1 SWOT ANALYSIS
- 3.2. POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4. POST COVID ANALYSIS
- 4.1. COVID V ANALYSIS
- 4.2. COVID U ANALYSIS
- 4.3. COVID L ANALYSIS
- 4.4. COVID W ANALYSIS
5. COMPANIES ANALYSIS
- 5.1. PLAYERS COVERED: RANKING BY PEN NEEDLES MARKET REVENUE
- 5.2. TOP COMPANIES MARKET SHARE (%)
6. EXECUTIVE SUMMARY
7. GLOBAL PEN NEEDLES MARKET FORECAST, 2022-2035, (USD MILLION)
- 7.1. GLOBAL PEN NEEDLES MARKET REVENUE AND MARKET SHARE BY REGIONS
- 7.2. GLOBAL PEN NEEDLES MARKET AND MARKET SHARE BY REGION (2022-2029)
- 7.3. GLOBAL PEN NEEDLES MARKET AND MARKET SHARE BY REGION (2030-2035)
- 7.3.1.1 North America
- 7.3.1.2 Europe
- 7.3.1.3 Asia Pacific
- 7.3.1.4 Latin America
- 7.3.1.5 Middle East & Africa
8. NORTH AMERICA PEN NEEDLES MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 8.1. NORTH AMERICA PEN NEEDLES MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 8.2. NORTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 8.3. NORTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 8.3.1.1 United States
- 8.3.1.2 Canada
- 8.3.1.3 Mexico
9. EUROPE PEN NEEDLES MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 9.1. EUROPE PEN NEEDLES MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 9.2. EUROPE PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 9.3. EUROPE PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 9.3.1.1 United Kingdom
- 9.3.1.2 Germany
- 9.3.1.3 France
- 9.3.1.4 Spain
- 9.3.1.5 Italy
- 9.3.1.6 Rest of Europe
10. ASIA PACIFIC PEN NEEDLES MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 10.1. ASIA PACIFIC PEN NEEDLES MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 10.2. ASIA PACIFIC PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 10.3. ASIA PACIFIC PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 10.3.1.1 China
- 10.3.1.2 India
- 10.3.1.3 Japan
- 10.3.1.4 Australia
- 10.3.1.5 South Korea
- 10.3.1.6 Rest of Asia Pacific
11. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 11.1. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 11.2. MIDDLE EAST & AFRICA PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 11.3. MIDDLE EAST & AFRICA PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 11.3.1.1 Saudi Arabia
- 11.3.1.2 South Africa
- 11.3.1.3 Rest of MEA
12. LATIN AMERICA PEN NEEDLES MARKET ANALYSIS BY COUNTRIES, (USD MILLION)
- 12.1. LATIN AMERICA PEN NEEDLES MARKET REVENUE AND MARKET SHARE BY COUNTRIES
- 12.2. LATIN AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2022-2029)
- 12.3. LATIN AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY COUNTRY (2030-2035)
- 12.3.1.1 Brazil
- 12.3.1.2 Argentina
- 12.3.1.3 Rest of Latin America
13. GLOBAL PEN NEEDLES MARKET SEGMENT BY BY TYPE, (USD MILLION)
- 13.1. GLOBAL PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2022-2029)
- 13.2. GLOBAL PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2030-2035)
- 13.3. NORTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2022-2029)
- 13.4. NORTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2030-2035)
- 13.5. EUROPE PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2022-2029)
- 13.6. EUROPE PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2030-2035)
- 13.7. ASIA PACIFIC PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2022-2029)
- 13.8. ASIA PACIFIC PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2030-2035)
- 13.9. MIDDLE EAST & AFRICA PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2022-2029)
- 13.10. MIDDLE EAST & AFRICA PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2030-2035)
- 13.11. SOUTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2022-2029)
- 13.12. SOUTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY TYPE (2030-2035)
13. GLOBAL PEN NEEDLES MARKET SEGMENT BY BY LENGTH, (USD MILLION)
- 13.13. GLOBAL PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2022-2029)
- 13.14. GLOBAL PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2030-2035)
- 13.15. NORTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2022-2029)
- 13.16. NORTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2030-2035)
- 13.17. EUROPE PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2022-2029)
- 13.18. EUROPE PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2030-2035)
- 13.19. ASIA PACIFIC PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2022-2029)
- 13.20. ASIA PACIFIC PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2030-2035)
- 13.21. MIDDLE EAST & AFRICA PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2022-2029)
- 13.22. MIDDLE EAST & AFRICA PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2030-2035)
- 13.23. SOUTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2022-2029)
- 13.24. SOUTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY LENGTH (2030-2035)
13. GLOBAL PEN NEEDLES MARKET SEGMENT BY BY THERAPY, (USD MILLION)
- 13.25. GLOBAL PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2022-2029)
- 13.26. GLOBAL PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2030-2035)
- 13.27. NORTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2022-2029)
- 13.28. NORTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2030-2035)
- 13.29. EUROPE PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2022-2029)
- 13.30. EUROPE PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2030-2035)
- 13.31. ASIA PACIFIC PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2022-2029)
- 13.32. ASIA PACIFIC PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2030-2035)
- 13.33. MIDDLE EAST & AFRICA PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2022-2029)
- 13.34. MIDDLE EAST & AFRICA PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2030-2035)
- 13.35. SOUTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2022-2029)
- 13.36. SOUTH AMERICA PEN NEEDLES MARKET AND MARKET SHARE BY BY THERAPY (2030-2035)
14. COMPANY PROFILES
- 14.1. EMBECTA (BD)
- 14.1.1 COMPANY DETAIL
- 14.1.2 FINANCIALS (USD MILLIONS)
- 14.1.3 PRODUCT SUMMARY
- 14.1.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.2. NOVO NORDISK
- 14.2.1 COMPANY DETAIL
- 14.2.2 FINANCIALS (USD MILLIONS)
- 14.2.3 PRODUCT SUMMARY
- 14.2.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.3. B. BRAUN
- 14.3.1 COMPANY DETAIL
- 14.3.2 FINANCIALS (USD MILLIONS)
- 14.3.3 PRODUCT SUMMARY
- 14.3.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.4. YPSOMED AG
- 14.4.1 COMPANY DETAIL
- 14.4.2 FINANCIALS (USD MILLIONS)
- 14.4.3 PRODUCT SUMMARY
- 14.4.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.5. OWEN MUMFORD
- 14.5.1 COMPANY DETAIL
- 14.5.2 FINANCIALS (USD MILLIONS)
- 14.5.3 PRODUCT SUMMARY
- 14.5.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.6. TERUMO
- 14.6.1 COMPANY DETAIL
- 14.6.2 FINANCIALS (USD MILLIONS)
- 14.6.3 PRODUCT SUMMARY
- 14.6.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.7. NIPRO CORPORATION
- 14.7.1 COMPANY DETAIL
- 14.7.2 FINANCIALS (USD MILLIONS)
- 14.7.3 PRODUCT SUMMARY
- 14.7.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
- 14.8. HTL-STREFA
- 14.8.1 COMPANY DETAIL
- 14.8.2 FINANCIALS (USD MILLIONS)
- 14.8.3 PRODUCT SUMMARY
- 14.8.4 RECENT DEVELOPMENTS (MERGERS, ACQUISITION, LAUNCH & OTHERS)
15. CONCLUSION
16. REFERENCE LINK
17. APPENDIX
- 17.1. METHODOLOGY
- 17.2. RESEARCH DATA SOURCE
- 17.2.1 SECONDARY DATA
- 17.2.2 KEY DATA FROM SECONDARY
- 17.2.3 PRIMARY DATA
- 17.2.4 KEY DATA FROM PRIMARY
- 17.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
- 17.2.6 MARKET ESTIMATION
- 17.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
- 17.2.8 LEGAL DISCLAIMER
18. RESEARCH SCOPE
LIST OF TABLES
- TABLE 1. MARKET SEGMENT
- TABLE 2. GLOBAL PEN NEEDLES MARKET GROWTH RATE BY BY TYPE (2026-2035)
- TABLE 3. GLOBAL PEN NEEDLES MARKET GROWTH RATE BY BY LENGTH (2026-2035)
- TABLE 4. GLOBAL PEN NEEDLES MARKET GROWTH RATE BY BY THERAPY (2026-2035)
- TABLE 5. COMPANY'S RANK BY PEN NEEDLES MARKET REVENUE
- TABLE 6. GLOBAL PEN NEEDLES MARKET — MARKET SNAPSHOT & KEY BUYING CRITERIA, 2026–2035
- TABLE 7. GLOBAL PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 8. GLOBAL PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 9. GLOBAL PEN NEEDLES MARKET BY REGION, USD MILLION (2022-2029)
- TABLE 10. GLOBAL PEN NEEDLES MARKET SHARE BY REGION, (2022-2029)
- TABLE 11. GLOBAL PEN NEEDLES MARKET BY REGION, USD MILLION (2030-2035)
- TABLE 12. GLOBAL PEN NEEDLES MARKET SHARE BY REGION, (2030-2035)
- TABLE 13. NORTH AMERICA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 14. NORTH AMERICA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 15. EUROPE PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 16. EUROPE PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 17. ASIA PACIFIC PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 18. ASIA PACIFIC PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 19. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 20. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 21. LATIN AMERICA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 22. LATIN AMERICA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 23. NORTH AMERICA PEN NEEDLES MARKET BY COUNTRY, (2022-2029)
- TABLE 24. NORTH AMERICA PEN NEEDLES MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 25. NORTH AMERICA PEN NEEDLES MARKET BY COUNTRY, (2030-2035)
- TABLE 26. NORTH AMERICA PEN NEEDLES MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 27. UNITED STATES PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 28. UNITED STATES PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 29. CANADA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 30. CANADA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 31. MEXICO PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 32. MEXICO PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 33. EUROPE PEN NEEDLES MARKET BY COUNTRY, (2022-2029)
- TABLE 34. EUROPE PEN NEEDLES MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 35. EUROPE PEN NEEDLES MARKET BY COUNTRY, (2030-2035)
- TABLE 36. EUROPE PEN NEEDLES MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 37. UNITED KINGDOM PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 38. UNITED KINGDOM PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 39. GERMANY PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 40. GERMANY PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 41. FRANCE PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 42. FRANCE PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 43. SPAIN PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 44. SPAIN PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 45. ITALY PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 46. ITALY PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 47. REST OF EUROPE PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 48. REST OF EUROPE PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 49. ASIA PACIFIC PEN NEEDLES MARKET BY COUNTRY, (2022-2029)
- TABLE 50. ASIA PACIFIC PEN NEEDLES MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 51. ASIA PACIFIC PEN NEEDLES MARKET BY COUNTRY, (2030-2035)
- TABLE 52. ASIA PACIFIC PEN NEEDLES MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 53. CHINA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 54. CHINA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 55. INDIA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 56. INDIA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 57. JAPAN PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 58. JAPAN PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 59. AUSTRALIA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 60. AUSTRALIA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 61. SOUTH KOREA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 62. SOUTH KOREA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 63. REST OF ASIA PACIFIC PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 64. REST OF ASIA PACIFIC PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 65. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET BY COUNTRY, (2022-2029)
- TABLE 66. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 67. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET BY COUNTRY, (2030-2035)
- TABLE 68. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 69. SAUDI ARABIA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 70. SAUDI ARABIA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 71. SOUTH AFRICA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 72. SOUTH AFRICA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 73. REST OF MEA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 74. REST OF MEA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 75. LATIN AMERICA PEN NEEDLES MARKET BY COUNTRY, (2022-2029)
- TABLE 76. LATIN AMERICA PEN NEEDLES MARKET SHARE BY COUNTRY, (2022-2029)
- TABLE 77. LATIN AMERICA PEN NEEDLES MARKET BY COUNTRY, (2030-2035)
- TABLE 78. LATIN AMERICA PEN NEEDLES MARKET SHARE BY COUNTRY, (2030-2035)
- TABLE 79. BRAZIL PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 80. BRAZIL PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 81. ARGENTINA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 82. ARGENTINA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 83. REST OF LATIN AMERICA PEN NEEDLES MARKET, (USD MILLION) (2022-2029)
- TABLE 84. REST OF LATIN AMERICA PEN NEEDLES MARKET, (USD MILLION) (2030-2035)
- TABLE 85. GLOBAL PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2022-2029)
- TABLE 86. GLOBAL PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2030-2035)
- TABLE 87. NORTH AMERICA PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2022-2029)
- TABLE 88. NORTH AMERICA PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2030-2035)
- TABLE 89. EUROPE PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2022-2029)
- TABLE 90. EUROPE PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2030-2035)
- TABLE 91. ASIA PACIFIC PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2022-2029)
- TABLE 92. ASIA PACIFIC PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2030-2035)
- TABLE 93. MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2022-2029)
- TABLE 94. MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2030-2035)
- TABLE 95. SOUTH AMERICA PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2022-2029)
- TABLE 96. SOUTH AMERICA PEN NEEDLES MARKET BY BY TYPE, USD MILLION (2030-2035)
- TABLE 97. GLOBAL PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2022-2029)
- TABLE 98. GLOBAL PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2030-2035)
- TABLE 99. NORTH AMERICA PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2022-2029)
- TABLE 100. NORTH AMERICA PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2030-2035)
- TABLE 101. EUROPE PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2022-2029)
- TABLE 102. EUROPE PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2030-2035)
- TABLE 103. ASIA PACIFIC PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2022-2029)
- TABLE 104. ASIA PACIFIC PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2030-2035)
- TABLE 105. MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2022-2029)
- TABLE 106. MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2030-2035)
- TABLE 107. SOUTH AMERICA PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2022-2029)
- TABLE 108. SOUTH AMERICA PEN NEEDLES MARKET BY BY LENGTH, USD MILLION (2030-2035)
- TABLE 109. GLOBAL PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2022-2029)
- TABLE 110. GLOBAL PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2030-2035)
- TABLE 111. NORTH AMERICA PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2022-2029)
- TABLE 112. NORTH AMERICA PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2030-2035)
- TABLE 113. EUROPE PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2022-2029)
- TABLE 114. EUROPE PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2030-2035)
- TABLE 115. ASIA PACIFIC PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2022-2029)
- TABLE 116. ASIA PACIFIC PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2030-2035)
- TABLE 117. MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2022-2029)
- TABLE 118. MIDDLE EAST & AFRICA PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2030-2035)
- TABLE 119. SOUTH AMERICA PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2022-2029)
- TABLE 120. SOUTH AMERICA PEN NEEDLES MARKET BY BY THERAPY, USD MILLION (2030-2035)
LIST OF FIGURES
- FIGURE 1. MARKET OVERVIEW
- FIGURE 2. REGIONAL SHARE
- FIGURE 3. MARKET REVENUE (USD MILLION)
- FIGURE 4. DROC OF PEN NEEDLES MARKET ANALYSIS
- FIGURE 5. SWOT ANALYSIS
- FIGURE 6. PESTEL ANALYSIS
- FIGURE 7. PORTER'S FIVE FORCES ANALYSIS
- FIGURE 8. COVID V, U, W AND L ANALYSIS
- FIGURE 9. LEADING COMPANIES
- FIGURE 10. REGIONAL ANALYSIS
- FIGURE 11. COUNTRY ANALYSIS
- FIGURE 12. GLOBAL PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 13. GLOBAL PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 14. GLOBAL PEN NEEDLES MARKET, (2022-2029), (USD MILLION), BY REGION
- FIGURE 15. GLOBAL PEN NEEDLES MARKET SHARE, (2026), BY REGION
- FIGURE 16. GLOBAL PEN NEEDLES MARKET, (2030-2035), (USD MILLION), BY REGION
- FIGURE 17. GLOBAL PEN NEEDLES MARKET SHARE, (2035), BY REGION
- FIGURE 18. NORTH AMERICA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 19. NORTH AMERICA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 20. EUROPE PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 21. EUROPE PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 22. ASIA PACIFIC PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 23. ASIA PACIFIC PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 24. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 25. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 26. LATIN AMERICA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 27. LATIN AMERICA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 28. NORTH AMERICA PEN NEEDLES MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 29. NORTH AMERICA PEN NEEDLES MARKET SHARE, (2026), BY COUNTRY
- FIGURE 30. NORTH AMERICA PEN NEEDLES MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 31. NORTH AMERICA PEN NEEDLES MARKET SHARE, (2035), BY COUNTRY
- FIGURE 32. UNITED STATES PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 33. UNITED STATES PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 34. CANADA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 35. CANADA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 36. MEXICO PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 37. MEXICO PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 38. EUROPE PEN NEEDLES MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 39. EUROPE PEN NEEDLES MARKET SHARE, (2026), BY COUNTRY
- FIGURE 40. EUROPE PEN NEEDLES MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 41. EUROPE PEN NEEDLES MARKET SHARE, (2035), BY COUNTRY
- FIGURE 42. UNITED KINGDOM PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 43. UNITED KINGDOM PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 44. GERMANY PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 45. GERMANY PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 46. FRANCE PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 47. FRANCE PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 48. SPAIN PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 49. SPAIN PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 50. ITALY PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 51. ITALY PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 52. REST OF EUROPE PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 53. REST OF EUROPE PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 54. ASIA PACIFIC PEN NEEDLES MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 55. ASIA PACIFIC PEN NEEDLES MARKET SHARE, (2026), BY COUNTRY
- FIGURE 56. ASIA PACIFIC PEN NEEDLES MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 57. ASIA PACIFIC PEN NEEDLES MARKET SHARE, (2035), BY COUNTRY
- FIGURE 58. CHINA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 59. CHINA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 60. INDIA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 61. INDIA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 62. JAPAN PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 63. JAPAN PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 64. AUSTRALIA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 65. AUSTRALIA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 66. SOUTH KOREA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 67. SOUTH KOREA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 68. REST OF ASIA PACIFIC PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 69. REST OF ASIA PACIFIC PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 70. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 71. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET SHARE, (2026), BY COUNTRY
- FIGURE 72. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 73. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET SHARE, (2035), BY COUNTRY
- FIGURE 74. SAUDI ARABIA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 75. SAUDI ARABIA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 76. SOUTH AFRICA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 77. SOUTH AFRICA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 78. REST OF MEA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 79. REST OF MEA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 80. LATIN AMERICA PEN NEEDLES MARKET, (2022-2029), (USD MILLION), BY COUNTRY
- FIGURE 81. LATIN AMERICA PEN NEEDLES MARKET SHARE, (2026), BY COUNTRY
- FIGURE 82. LATIN AMERICA PEN NEEDLES MARKET, (2030-2035), (USD MILLION), BY COUNTRY
- FIGURE 83. LATIN AMERICA PEN NEEDLES MARKET SHARE, (2035), BY COUNTRY
- FIGURE 84. BRAZIL PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 85. BRAZIL PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 86. ARGENTINA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 87. ARGENTINA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
- FIGURE 88. REST OF LATIN AMERICA PEN NEEDLES MARKET, (2022-2029), (USD MILLION)
- FIGURE 89. REST OF LATIN AMERICA PEN NEEDLES MARKET, (2030-2035), (USD MILLION)
Research Methodology
Our research methodology is carefully designed to deliver the clients with the most accurate, relevant, and actionable market insights to enable clear decision-making and leveraging of opportunities in the markets. We believe consistency, depth in analysis, and a tailored approach in each report are what help set us apart in the industry. The research methodology is based on an integrating research process consisting of in-depth data collection, a complex analysis, and a stringent validation system.
Data Collection
Data collection forms the basis of our study and gathers diverse authentic data to build the basis for deeper study in terms of market trends, competitive landscape, and growth prospects. Data collection takes place through two channels of main activities as follows:
Primary Data Collection
Primary data collection allows collecting real-time and firsthand information from market participants. This is an engagement process conducted by our team with other industry stakeholders, where a much deeper insight than any published data is pursued. This process includes:
- Direct Interviews – We interview the key decision-makers such as CEOs, product managers, innovation heads, and marketing directors to gather both qualitative and quantitative information. The questionnaire covers emerging trends, customer preferences, regulatory impact, and competitors’ strategies.
- Demand and Supply-Side Inputs – Interviews and surveys with supply and demand-side stakeholders provide a balanced view of prevailing market conditions, including feedback from manufacturers, distributors, suppliers, and end-users.
- Expert Opinions – Consultations with industry experts and domain specialists provide insights into future market direction, risks, and opportunities.
- Focus Groups and Online Surveys – Focus groups and surveys are used to understand consumer preferences and adoption probability of new products or services.
Primary research forms the core of our data validation process by offering direct insights into the market, addressing limitations in secondary data, and allowing for an adaptable research process.
Secondary Data Collection
Secondary research serves as a robust foundation for understanding market context, historical data, and larger trends. It involves systematic gathering of existing information from verified sources.
- Industry Reports and Publications – Market reports, white papers, and case studies from credible sources provide a broad view of the market landscape and key players.
- Government and Public Records – Data from government agencies and regulatory bodies helps analyze economic factors and policy impacts.
- News and Media Outlets – Monitoring news articles, press releases, and media reports keeps us updated on market developments and M&A activity.
- Proprietary and Paid Databases – Databases such as Bloomberg, Factiva, D&B Hoovers, and Thomson Reuters provide validated and cross-referenced data.
- Financial Reports and SEC Filings – Financial statements, annual reports, and investor presentations provide insights into revenue structures and profitability.
This combination of primary and secondary data sources enables us to provide a comprehensive view of the market, supported by authenticated information across multiple sources.
Data Analysis Techniques
With the data collected, we initiate a rigorous analysis phase. We analyze market dynamics, growth patterns, and future performance using analytical models and statistical tools.
Top-Down and Bottom-Up Market Sizing Approaches
- Top-Down Approach – Starts with global market size and distributes it across segments using macro-level trends and established proportions.
- Bottom-Up Approach – Aggregates company-level and country-level revenue data to build regional and global market estimates.
These two approaches are cross-validated to remove inconsistencies and ensure accurate market estimation.
Forecasting Models and Market Dynamics Analysis
- Time-Series Analysis – Models historical trends, seasonality, and demand cycles.
- Econometric and Judgmental Forecasting – Combines economic models with expert-driven adjustments.
- Delphi Method – Uses iterative expert input to generate balanced market forecasts.
Data Triangulation and Validation
- Multi-source cross-verification of all data points
- Use of quantitative and qualitative validation techniques
- Sample validation through expert and stakeholder feedback
Market Analysis and Sizing Estimation
- Detailed segmentation analysis
- Competitive landscape evaluation
- Revenue modeling using TAM, SAM, and SOM frameworks
Quality Assurance and Final Review
- Data accuracy and consistency checks
- Content, language, and structure review
- Client-specific customization and refinement
Continuous Improvement in Methodology
We continuously refine our research methodologies based on evolving market conditions, client feedback, and technological advancements. This ensures our research remains accurate, relevant, and aligned with industry standards.
Pen Needles Market Report Scope & Segmentation
| Attributes | Details |
|---|---|
| Market Size (Current)Current market valuation | US$ 1.86 Billion in 2026 |
| Market Size (Forecast)Projected market valuation | US$ 3.82 Billion in 2035 |
| Growth RateCompound Annual Growth Rate | CAGR of 8.3% from 2026 to 2035 |
| Forecast PeriodAnalysis timeline | 2026 – 2035 |
| Base YearReference year for analysis | 2025 |
| Historical Data AvailablePast market data availability | Yes |
| Regional ScopeGeographical coverage | Global |
| Segments CoveredMarket segments analyzed | By Type
By Length
By Therapy
|
Leading companies covered in this report
- Embecta (BD)
- Novo Nordisk
- B. Braun
- Ypsomed AG
- Owen Mumford
- Terumo
- NIPRO Corporation
- HTL-STREFA
Frequently Asked Questions
Common questions about this report
The study period covers historical insights and forecast projections for the period 2026-2035.
The global Pen Needles Market market is expected to grow at a CAGR of 8.3% during the forecast period 2026-2035.
The report offers comprehensive market segmentation analysis across key categories and sub-segments relevant to the industry, along with regional and competitive insights.
The market is projected to reach 3.82 Billion by 2035.
Embecta (BD), Novo Nordisk, B. Braun, Ypsomed AG, Owen Mumford, Terumo, NIPRO Corporation, HTL-STREFA.
North America, Europe, and Asia Pacific are key regions covered in the report, including regional trends, market share, and growth opportunities.
Growing demand, technological advancements, changing consumer preferences, and increasing investments are some of the major factors supporting the growth of the Pen Needles Market market.
Yes, the report includes company profiling, competitive landscape analysis, strategic developments, mergers & acquisitions, product launches, and market positioning of leading industry participants.
The report is prepared using a combination of primary research, secondary research, expert interviews, industry databases, company annual reports, and proprietary market analysis models.
Yes, report customization options are available based on specific business objectives, geographic focus, competitive benchmarking requirements, and additional market segmentation needs.
Yes, the report is available in both PDF and Excel formats. The Excel file includes all market data tables, forecasts, and segment-wise data for easy analysis.
Yes, you can request a free sample report which includes an overview, table of contents, and sample data pages to help you evaluate the report before making a purchase decision.
About the Author
Market research expert with years of industry experience
